H&T Presspart, a global leader and expert in the manufacture of metered-dose inhalers, will be attending the upcoming 11th Digital Pharma Europe event on the 4th – 6th June taking place in Rome, Italy.

The 11th Digital Pharma Europe aims at helping pharma professionals understand how to adapt to the rapidly changing global healthcare ecosystem, and to the rapidly changing needs and dynamics of its customers.

H&T Presspart’s Dr Benjamin Jung will be attending and delivering a speech entitled “The Future of Connected Asthma and COPD Care: A Stepwise Development” on day two of the event at 15:30. He will be using H&T Presspart’s eMDI, the first market-ready, fully embedded and connected metered-dose inhaler, as a case study.

The eMDI connected metered-dose inhaler enables patients to track and record data on the use of their medications, whilst being able to share it with their healthcare professionals. The eMDI enables pharmaceutical manufacturers to bring the best possible care to those with asthma and COPD.

This year’s host venue at Merck Serono in Rome blends world-class facilities, with an engaged pharmaceutical partner and an incredible city destination and is set to be a great event.

For any more information or to arrange a meeting with Dr Jung during the conference please contact us.